Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) are the standard of care for non‐small‐cell lung cancer (NSCLC) patients harboring EGFR mutations. However, almost all patients develop resistance after approximately 1 y of treatment, with >50% of cases due to the T790M se...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Hirashima, Tomonori, Satouchi, Miyako, Hida, Toyoaki, Nishio, Makoto, Kato, Terufumi, Sakai, Hiroshi, Imamura, Fumio, Kiura, Katsuyuki, Okamoto, Isamu, Kasahara, Kazuo, Uchida, Hirohiko, Vowler, Sarah L., Mitsudomi, Tetsuya
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726692/
https://ncbi.nlm.nih.gov/pubmed/31265163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14120
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi